Neurology

Neurology

  • First Report Managed Care

    Richard G Wenzel, PharmD, pharmacologist at the Diamond Headache Inpatient Unit, discusses novel therapies for acute migraines that will soon be FDA-approved and will provide an opportunity to reassess migraine approaches for this undertreated and widespread illness.

Online Exclusives

Articles